The crosstalk between thyroid hormones and the Renin-Angiotensin System

Vascular Pharmacology

Volumn 52, Issue 3-4, 2010, Pages 166-170

  Barreto Chaves, Maria Luiza M ^a   Carrillo Sepúlveda, Maria Alícia ^a   Carneiro Ramos, Marcela S ^a   Gomes, Dayane A ^a   Diniz, Gabriela P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiac hypertrophy; Renin Angiotensin System; Thyroid hormones; Vasodilatation

Indexed keywords

THYROID HORMONE;

CARDIOVASCULAR SYSTEM; FETUS GROWTH; HORMONE ACTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; NEWBORN PERIOD; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ADULT; ANIMALS; CARDIOVASCULAR DISEASES; DRUG DELIVERY SYSTEMS; FETAL DEVELOPMENT; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INFANT, NEWBORN; RENIN-ANGIOTENSIN SYSTEM; THYROID HORMONES;

EID: 76849102126     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.10.009     Document Type: Review

References (71)

1. Aras O., Messina S.A., Shirani J., Eckelman W.C., and Dilsizian V. The role and regulation of cardiac angiotensin-converting enzyme for noninvasive molecular imaging in heart failure. Curr. Cardiol. Rep. 9 (2007) 150-158
2. Asahi T., Shimabukuro M., Oshiro Y., Yoshida H., and Takasu N. Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats. Thyroid 11 (2001) 1009-1015
3. Bader M., and Ganten D. Update on tissue renin-angiotensin systems. J. Mol. Med. 86 (2008) 615-621
4. Basset A., Blanc J., Messas E., Hagege A., and Elghozi J.L. Renin-angiotensin system contribution to cardiac hypertrophy in experimental hyperthyroidism: an echocardiographic study. J. Cardiovasc. Pharmacol. 37 (2001) 163-172
5. Bomback A.S., and Toto R. Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination. Am. J. Hypertens. (2009) 10.1038/ajh.2009.138
6. Bouhnik J., Galen F.X., Clauser E., Menard J., and Corvol P. The renin-angiotensin system in thyroidectomized rats. Endocrinology 108 (1981) 647-650
7. Brent G.A. The molecular basis of thyroid hormone action. N. Engl. J. Med. 331 (1994) 847-853
8. Carneiro-Ramos M.S., Silva V.B., Santos R.A., and Barreto-Chaves M.L. Tissue-specific modulation of angiotensin-converting enzyme (ACE) in hyperthyroidism. Peptides 27 (2006) 2942-2949
9. Carneiro-Ramos M.S., Diniz G.P., Almeida J., Vieira R.L., Pinheiro S.V., Santos R.A., and Barreto-Chaves M.L. Cardiac angiotensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism. J. Physiol. 583 (2007) 213-223
10. Carrillo-Sepulveda M.A., Ceravolo G.S., Fortes Z.B., Carvalho M.H., Tostes R., Laurindo F.R., Webb R.C., and Barreto-Chaves M.L. Thyroid hormone stimulates nitric oxide production via activation of the phosphatidylinositol-3-kinase/Akt pathway in vascular myocytes. Cardiovasc. Res. (2009) 10.1093/cvr/cvp304
11. Chen K., Carey L.C., Valego N.K., Liu J., and Rose J.C. Thyroid hormone modulates renin and ANG II receptor expression in fetal sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 (2005) R1006-R1014
12. Chen K., Carey L.C., Valego N.K., and Rose J.C. Thyroid hormone replacement normalizes renal renin and angiotensin receptor expression in thyroidectomized fetal sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293 (2007) R701-R706
13. Costerousse O., Allegrini J., Huang H., Bounhik J., and Alhenc-Gelas F. Regulation of ACE gene expression and plasma levels during rat postnatal development. Am. J. Physiol. 267 (1994) E745-E753
14. Cristovam P.C., Arnoni C.P., de Andrade M.C., Casarini D.E., Pereira L.G., Schor N., and Boim M.A. ACE-dependent and chymase-dependent angiotensin II generation in normal and glucose-stimulated human mesangial cells. Exp. Biol. Med. (Maywood). 233 (2008) 1035-1043
15. D'Amore A., Black M.J., and Thomas W.G. The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy. Hypertension 46 (2005) 1347-1354
16. Danser A.H. Local renin-angiotensin systems. Mol. Cell. Biochem. 157 (1996) 211-216
17. Davis P.J., and Davis F.B. Nongenomic actions of thyroid hormone. Thyroid 6 (1996) 497-504
18. Davis P.J., and Davis F.B. Nongenomic actions of thyroid hormone on the heart. Thyroid 12 (2002) 459-466
19. Diniz G.P., Carneiro-Ramos M.S., and Barreto-Chaves M.L. Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-beta1 in thyroid hormone-induced cardiac hypertrophy. Pflugers. Arch. 454 (2007) 75-81
20. Diniz G.P., Carneiro-Ramos M.S., and Barreto-Chaves M.L. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway. Basic. Res. Cardiol. (2009) 10.1007/s00395-009-0043-1
21. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., Breitbart R.E., and Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87 (2000) E1-E9
22. Dzau V.J., and Re R. Tissue angiotensin system in cardiovascular medicine. A paradigm shift?. Circulation 89 (1994) 493-498
23. Elias A.N., Kyaw T., Valenta L.J., and Meshkinpour H. The renin-angiotensin system in hypothyroidism of short duration. Horm. Metab. Res. 18 (1986) 349-351
24. Fukuyama K., Ichiki T., Takeda K., Tokunou T., Iino N., Masuda S., Ishibashi M., Egashira K., Shimokawa H., Hirano K., Kanaide H., and Takeshita A. Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone. Hypertension 41 (2003) 598-603
25. Ganong W.F. Thyroid hormones and renin secretion. Life. Sci. 30 (1982) 561-569
26. Gotoh M., Mizuno K., Matsui J., Kunii N., and Fukuchi S. Serum angiotensin I converting enzyme activity in patients with hyperthyroidism and hypothyroidism: relation to renin and aldosterone. Nippon. Naibunpi. Gakkai. Zasshi. 60 (1984) 835-845
27. Goulart da Silva F., Giannocco G., Santos M.F., and Nunes M.T. Thyroid hormone induction of actin polymerization in somatotrophs of hypothyroid rats: potential repercussions in growth hormone synthesis and secretion. Endocrinology 147 (2006) 5777-5785
28. Graettinger J.S., Muenster J.J., Selverstone L.A., and Campbell J.A. A correlation of clinical and hemodynamic studies in patients with hyperthyroidism with and without congestive heart failure. J. Clin. Invest. 38 (1959) 1316-1327
29. Guang-da X., Hong-yan C., and Xian-mei Z. Changes in endothelium-dependent arterial dilation before and after subtotal thyroidectomy in subjects with hyperthyroidism. Clin. Endocrinol. (Oxf) 61 (2004) 400-404
30. Hak A.E., Pols H.A., Visser T.J., Drexhage H.A., Hofman A., and Witteman J.C. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann. Intern. Med. 132 (2000) 270-278
31. Hiroi Y., Kim H.H., Ying H., Furuya F., Huang Z., Simoncini T., Noma K., Ueki K., Nguyen N.H., Scanlan T.S., Moskowitz M.A., Cheng S.Y., and Liao J.K. Rapid nongenomic actions of thyroid hormone. Proc. Natl. Acad. Sci. USA. 103 (2006) 14104-14109
32. Hong-Brown L.Q., and Deschepper C.F. Effects of thyroid hormones on angiotensinogen gene expression in rat liver, brain, and cultured cells. Endocrinology 130 (1992) 1231-1237
33. Hu L.W., Benvenuti L.A., Liberti E.A., Carneiro-Ramos M.S., and Barreto-Chaves M.L. Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 (2003) R1473-R1480
34. Jimenez E., Montiel M., Narvaez J.A., and Morell M. Renin-angiotensin system in hypothyroid rats: effects of potassium iodide and triiodo-L-thyronine. Acta. Endocrinol. (Copenh) 105 (1984) 505-510
35. Kahaly G.J., and Dillmann W.H. Thyroid hormone action in the heart. Endocr. Rev. 26 (2005) 704-728
36. Kapitola J., and Vilimovska D. Inhibition of the early circulatory effects of triiodothyronine in rats by propranolol. Physiol. Bohemoslov. 30 (1981) 347-351
37. Kenessey A., and Ojamaa K. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J. Biol. Chem. 281 (2006) 20666-20672
38. Klein I., and Danzi S. Thyroid disease and the heart. Circulation 116 (2007) 1725-1735
39. Klein I., and Ojamaa K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344 (2001) 501-509
40. Klemperer J.D., Klein I., Gomez M., Helm R.E., Ojamaa K., Thomas S.J., Isom O.W., and Krieger K. Thyroid hormone treatment after coronary-artery bypass surgery. N. Engl. J. Med. 333 (1995) 1522-1527
41. Kobori H., Ichihara A., Suzuki H., Miyashita Y., Hayashi M., and Saruta T. Thyroid hormone stimulates renin synthesis in rats without involving the sympathetic nervous system. Am. J. Physiol. 272 (1997) E227-E232
42. Kobori H., Ichihara A., Suzuki H., Takenaka T., Miyashita Y., Hayashi M., and Saruta T. Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism. Am. J. Physiol. 273 (1997) H593-H599
43. Krasner L.J., Wendling W.W., Cooper S.C., Chen D., Hellmann S.K., Eldridge C.J., McClurken J.B., Jeevanandam V., and Carlsson C. Direct effects of triiodothyronine on human internal mammary artery and saphenous veins. J. Cardiothorac. Vasc. Anesth. 11 (1997) 463-466
44. Kumar R., Singh V.P., and Baker K.M. The intracellular renin-angiotensin system: a new paradigm. Trends. Endocrinol. Metab. 18 (2007) 208-214
45. Kuzman J.A., Gerdes A.M., Kobayashi S., and Liang Q. Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes. J. Mol. Cell. Cardiol. 39 (2005) 841-844
46. Kuzman J.A., O'Connell T.D., and Gerdes A.M. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy. Endocrinology 148 (2007) 3477-3484
47. Lavoie J.L., and Sigmund C.D. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 144 (2003) 2179-2183
48. Lavrentyev E.N., Estes A.M., and Malik K.U. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells. Circ. Res. 101 (2007) 455-464
49. Letizia C., Centanni M., De Ciocchis A., Pontecorvi A., Cerci S., Vermiglio F., Scaramazza U., and Scavo D. Reduced serum angiotensin converting enzyme activity in children with congenital hypothyroidism. Horm. Metab. Res. 26 (1994) 243-245
50. Marchant C., Brown L., and Sernia C. Renin-angiotensin system in thyroid dysfunction in rats. J. Cardiovasc. Pharmacol. 22 (1993) 449-455
51. Matilla M.J., Montiel M., and Jimenez E. Angiotensin II (AII) and adrenal gland AII receptors in rats with congenital hypothyroidism. J. Endocrinol. 137 (1993) 231-238
52. McAllister R.M., Grossenburg V.D., Delp M.D., and Laughlin M.H. Effects of hyperthyroidism on vascular contractile and relaxation responses. Am. J. Physiol. 274 (1998) E946-E953
53. Montiel M., Jimenez E., Navaez J.A., and Morell M. Aldosterone and plasma renin activity in hyperthyroid rats: effects of propranolol and propylthiouracil. J. Endocrinol. Invest. 7 (1984) 559-562
54. Montiel M., Diaz F., Quesada J., and Jimenez E. Ontogeny of renal renin in congenital hypothyroid rats. Life. Sci. 65 (1999) 263-269
55. Napoli R., Guardasole V., Angelini V., Zarra E., Terracciano D., D'Anna C., Matarazzo M., Oliviero U., Macchia V., and Sacca L. Acute effects of triiodothyronine on endothelial function in human subjects. J. Clin. Endocrinol. Metab. 92 (2007) 250-254
56. Ojamaa K., Klemperer J.D., and Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6 (1996) 505-512
57. Pantos C., Paizis I., Mourouzis I., Moraitis P., Tzeis S., Karamanoli E., Mourouzis C., Karageorgiou H., and Cokkinos D.V. Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning. Horm. Metab. Res. 37 (2005) 500-504
58. Park K.W., Dai H.B., Ojamaa K., Lowenstein E., Klein I., and Sellke F.W. The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth. Analg. 85 (1997) 734-738
59. Paul M., Poyan Mehr A., and Kreutz R. Physiology of local renin-angiotensin systems. Physiol. Rev. 86 (2006) 747-803
60. Robillard J.E., and Segar J.L. Influence of early life events on health and diseases. Trans. Am. Clin. Climatol. Assoc. 117 (2006) 319-320
61. Santos R.A., Simoes e Silva A.C., Maric C., Silva D.M., Machado R.P., de Buhr I., Heringer-Walther S., Pinheiro S.V., Lopes M.T., Bader M., Mendes E.P., Lemos V.S., Campagnole-Santos M.J., Schultheiss H.P., Speth R., and Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 8258-8263
62. Santos R.A., Ferreira A.J., and Simoes E.S.A.C. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp. Physiol. 93 (2008) 519-527
63. Schluter K.D., and Wenzel S. Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks. Pharmacol. Ther. 119 (2008) 311-325
64. Senbonmatsu T., Ichihara S., Price Jr. E., Gaffney F.A., and Inagami T. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J. Clin. Invest. 106 (2000) R25-R29
65. Senbonmatsu T., Saito T., Landon E.J., Watanabe O., Price Jr. E., Roberts R.L., Imboden H., Fitzgerald T.G., Gaffney F.A., and Inagami T. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. Embo. J. 22 (2003) 6471-6482
66. Sernia C., Marchant C., Brown L., and Hoey A. Cardiac angiotensin receptors in experimental hyperthyroidism in dogs. Cardiovasc. Res. 27 (1993) 423-428
67. Su L., Dai Y., Deng W., and Yin Y.H. Renin-angiotensin system blocking agents reverse the myocardial hypertrophy in experimental hyperthyroid cardiomyopathy via altering intracellular calcium handling. Zhonghua. Xin. Xue. Guan. Bing. Za. Zhi. 36 (2008) 744-749
68. Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., and Turner A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275 (2000) 33238-33243
69. Yoneda K., Takasu N., Higa S., Oshiro C., Oshiro Y., Shimabukuro M., and Asahi T. Direct effects of thyroid hormones on rat coronary artery: nongenomic effects of triiodothyronine and thyroxine. Thyroid 8 (1998) 609-613
70. Zdrojewicz Z. Plasma renin activity in women with hyperthyroidism. Pol. Arch. Med. Wewn. 86 (1991) 101-106
71. Zdrojewicz Z., and Plamieniak Z. Plasma renin activity in women with hypothyroidism. Pol. Tyg. Lek. 48 (1993) 595-598